The first 3 days of trading following the dividend announcement have been 30%-50% each day. Even if it's only 20% per day by Friday it would be close to the $1 mark (~$.90). Let's say we keep the 30% going and it would be over $1.25.
Take into account that the more shares that are bought, the more the float is getting locked up and dwindling supply of available shares is going to push up the price per share exponentially.
The very situation that we were expecting FDA approval news to rocket the price per share is being demonstrated here, on a much smaller scale, mind you. RGBP is still trading at a fraction of the volume that I believe clinical trial approval will bring.
What we are watching here lately is just a preview of things to come, just a morsel of the whole cookie. Can't wait to watch.
Go RGBP!! b:-)d
News 
Market Data 
Discover 
AI
